LEVETIRACETAM DEXCEL 750

Ülke: İsrail

Dil: İngilizce

Kaynak: Ministry of Health

Aktif bileşen:

LEVETIRACETAM

Mevcut itibaren:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC kodu:

N03AX14

Farmasötik formu:

TABLETS

Kompozisyon:

LEVETIRACETAM 750 MG

Uygulama yolu:

PER OS

Reçete türü:

Required

Tarafından üretildi:

DEXCEL LTD, ISRAEL

Terapötik grubu:

LEVETIRACETAM

Terapötik alanı:

LEVETIRACETAM

Terapötik endikasyonlar:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Yetkilendirme tarihi:

2018-03-31